Michael Torok, Ph.D., currently serves as the Vice President and Global Head of Quality Assurance Programs at Roche/Genentech, leading strategies in risk management and quality evidence delivery for new therapeutics. Previously, Michael held various senior positions at Astellas Pharma US, focusing on clinical quality assurance, process improvement, and operational excellence. Michael's extensive experience includes leadership roles at PAREXEL and PRA Health Sciences, where significant clinical studies were managed. A proven innovator, Michael led efforts in drug development at Adial Pharmaceuticals and was a Chief Scientific Officer at Global Cell Solutions Inc., where notable advancements in cell culture technology were achieved. Michael's educational background includes a Ph.D. in Biochemistry and Molecular Genetics from the University of Virginia, along with certifications in data analytics.